AVO announces £6m fundraise

Advanced Oncotherapy CEO Nicolas Serandour

Proton beam therapy specialist Advanced Oncotherapy (AVO) has announced a £6m equity fundraise to support its operations following news that it expects to treat the first patient…

You must be a HM Subscriber to view this content.

Subscribe Now »